Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (151-160 of 356) with videos related to

Pageof 36
Sort By:
The European Respiratory Journal|October 20, 2018
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)Ganesh Raghu, Luca Richeldi, Bruno Crestani, et al.
Journal of Clinical Medicine|July 29, 2025
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary FibrosisGiorgio Monteleone, Luca Passantino, Jacopo Simonetti, et al.
Expert Opinion on Pharmacotherapy|September 22, 2017
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?Riccardo Inchingolo, Carola Condoluci, Andrea Smargiassi, et al.
Expert Opinion on Drug Safety|August 18, 2016
The safety of new drug treatments for idiopathic pulmonary fibrosisSophie Fletcher, Mark G Jones, Katherine Spinks, et al.
Expert Review of Respiratory Medicine|May 26, 2017
New treatment directions for IPF: current status of ongoing and upcoming clinical trialsFrancesco Macagno, Francesco Varone, Paolo Maria Leone, et al.
BMC Pulmonary Medicine|July 18, 2021
Residual respiratory impairment after COVID-19 pneumoniaFrancesco Lombardi, Angelo Calabrese, Bruno Iovene, et al.
Respiration; International Review of Thoracic Diseases|March 24, 2026
High-Frequency Chest Wall Oscillation in Critical Care: A Systematic ReviewSimone Ielo, Lorenzo Carriera, Roberto Barone, et al.
American Journal of Respiratory and Critical Care Medicine|September 26, 2025
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special SectionPatricia J Sime, Luca Richeldi, Anna J Podolanczuk, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosisPaola Contini, Mario Schiavina, Riccardo Schiavina, et al.
The Lancet. Respiratory Medicine|May 16, 2015
CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner SocietyDavid M Hansell, Jonathan G Goldin, Talmadge E King, et al.
Pageof 36

Showing results (151-160 of 356) with videos related to

Sort By:
Pageof 36
The European Respiratory Journal|October 20, 2018
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)Ganesh Raghu, Luca Richeldi, Bruno Crestani, et al.
Journal of Clinical Medicine|July 29, 2025
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary FibrosisGiorgio Monteleone, Luca Passantino, Jacopo Simonetti, et al.
Expert Opinion on Pharmacotherapy|September 22, 2017
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?Riccardo Inchingolo, Carola Condoluci, Andrea Smargiassi, et al.
Expert Opinion on Drug Safety|August 18, 2016
The safety of new drug treatments for idiopathic pulmonary fibrosisSophie Fletcher, Mark G Jones, Katherine Spinks, et al.
Expert Review of Respiratory Medicine|May 26, 2017
New treatment directions for IPF: current status of ongoing and upcoming clinical trialsFrancesco Macagno, Francesco Varone, Paolo Maria Leone, et al.
BMC Pulmonary Medicine|July 18, 2021
Residual respiratory impairment after COVID-19 pneumoniaFrancesco Lombardi, Angelo Calabrese, Bruno Iovene, et al.
Respiration; International Review of Thoracic Diseases|March 24, 2026
High-Frequency Chest Wall Oscillation in Critical Care: A Systematic ReviewSimone Ielo, Lorenzo Carriera, Roberto Barone, et al.
American Journal of Respiratory and Critical Care Medicine|September 26, 2025
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special SectionPatricia J Sime, Luca Richeldi, Anna J Podolanczuk, et al.
Multidisciplinary Respiratory Medicine|September 11, 2012
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosisPaola Contini, Mario Schiavina, Riccardo Schiavina, et al.
The Lancet. Respiratory Medicine|May 16, 2015
CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner SocietyDavid M Hansell, Jonathan G Goldin, Talmadge E King, et al.
Pageof 36